CytoDyn annual gross margin
2022
CytoDyn's gross margin was 80.08% for fiscal 2022.
View full CytoDyn company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2022 | 2022-05-31 | 80.08% | — |
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q2 2022 | 2021-11-30 | 76.89% | — |
| Q1 2022 | 2021-08-31 | 97.56% | — |
The latest reported quarter, Q2 2022, shows 76.89%.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review CytoDyn source filings ↗